(Q71906621)

English

A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III

scientific article published on 01 November 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8970248%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8970248%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

J B Serle

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8970248%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 November 1996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8970248%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Survey of Ophthalmology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8970248%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

41 Suppl 1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8970248%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

S39-47

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8970248%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982030-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with the long-term use of 1% apraclonidine. Incidence of allergic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982030-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interim report: National Registry of possible Drug-induced Ocular Side Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982030-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Average Partial Association in Three-Way Contingency Tables: A Review and Discussion of Alternative Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982030-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of apraclonidine and timolol in chronic open-angle glaucoma. A three-month study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982030-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982030-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term Effects of Unilateral 1% Apraclonidine Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982030-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982030-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of brimonidine on aqueous humor dynamics in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982030-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0039-6257(96)82030-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8970248%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8970248%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71906621&oldid=1899313499"